[1] Hems S, Lee A. Drug-induced renal disorders[J]. Pharm J, 1997, 259: 214.
[2] Larbi EB. Drug-induced rhabdomyolysis[J]. Ann Saudi Med, 1998, 18(6): 525.
[3] Alsheikh-Ali AA, Kuvin JT, Karas RH. Risk of adverse events with fibrates[J]. Am J Cardiol, 2004, 94(7): 935-938.
[4] Massy ZA, Ma JZ, Louis TA. Lipid-lowering therapy in patients with renal disease[J]. Kidney Int, 1995, 48: 188-198.
[5] Poels PJE, Gabriels FUM. Rhabdomyolysis: a review of the literature[J]. Clin Neurol Neurosurg, 1993, 95(3): 175.
[6] 李中东, 施孝金, 王大猷, 等. 药物引起的横纹肌溶解症[J]. 中国临床药学杂志,2003, 12(1): 54-58. |
